Home

Publications - page 313

Search for a publication

Filter

Publication dates

Units / departments

Teams / Groups

Plateforms

Journal name

Search for a publication

12613 result(s)

2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Thalidomide for refractory multiple myeloma: potential interest of a Dexamethasone adjonctionThérapie
2002Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrityEMBO reports
Show authors

Previous<

1 ...312 313 314...421

Next >